英赛德

最新新闻

• 评级变动
  Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• UBS Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $172
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $188
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• 评级变动
  Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $195
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $175
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $220
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Cantor Fitzgerald Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $235
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 评级变动
  BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $209
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $243
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $170 to $237
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $179
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $198
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  Guggenheim Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $207
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• 评级变动
  Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218
  \u5e02\u573a\u8d44\u8baf · 2026/9/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。